Voloridge Investment Management, LLC Tcr2 Therapeutics Inc. Transaction History

Voloridge Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.4 - $4.71 $64,255 - $126,100	-26,773 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.58 - $8.34 $122,620 - $223,286	26,773 New	26,773 $125,000
Q1 2021 May 17, 2021	SELL	$20.38 - $34.07 $256,849 - $429,384	-12,603 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.0 - $32.63 $239,457 - $411,235	12,603 New	12,603 $390,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.